HomeWOCKPHARMA › Filing
🔔 Get instant alerts when WOCKPHARMA files quarterly results on BSE Start free trial →
Wockhardt Limited (WOCKPHARMA)

Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICDR) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilisation ....

Filed: 10 Aug 2026, 18:38 IST Exchange: BSE Category: Regulatory Compliance — Monitoring Agency Report
Monitoring Agency Report for Q1 FY27 on QIP proceeds utilization - No deviation in utilization of QIP proceeds from objects stated in Nov 2024 Placement Document - Total QIP net proceeds Rs 977.79 Cr; Rs 500 Cr for borrowings repayment fully utilized - Rs 111.30 Cr utilized for capital expenditure and R&D; Rs 138.70 Cr unutilized as of June 30, 2026 - General corporate purposes Rs 227.79 Cr fully utilized - Timeline for capex/R&D utilization extended to FY28 end by Board resolution
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 WOCKPHARMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add WOCKPHARMA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Wockhardt Limited

Important. The summary above is generated automatically from Wockhardt Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.